Sanofi’s two patents on the cancer drug Taxotere were ruled invalid and unenforceable by a U.S. court today in a victory for generic-drug makers Hospira Inc. and Apotex Inc.
BostonGlobe.comSubscriber Log-in
Contact us for help
-
Phone
617-929-2233
Daily 8 a.m.-7 p.m.
-
Chat
Daily 7 a.m.-7 p.m.
Comments